Presentation is loading. Please wait.

Presentation is loading. Please wait.

Myocardial Ischemia: An Underrated Cause of Sudden Cardiac Death? William T. Abraham, MD, FACP, FACC, FAHA Professor of Medicine, Physiology, and Cell.

Similar presentations

Presentation on theme: "Myocardial Ischemia: An Underrated Cause of Sudden Cardiac Death? William T. Abraham, MD, FACP, FACC, FAHA Professor of Medicine, Physiology, and Cell."— Presentation transcript:

1 Myocardial Ischemia: An Underrated Cause of Sudden Cardiac Death? William T. Abraham, MD, FACP, FACC, FAHA Professor of Medicine, Physiology, and Cell Biology Chair of Excellence in Cardiovascular Medicine Chief, Division of Cardiovascular Medicine Deputy Director, Davis Heart & Lung Research Institute The Ohio State University Columbus, Ohio

2 Disclosures -Dr. Abraham has received research grants and/or consulting fees from Biotronik, Medtronic, and St. Jude Medical

3 Ohio State University Sudden Cardiac Death (SCD) Research Center


5 Adapted from Bayés de Luna A. Am Heart J. 1989;117: Underlying Arrhythmias of SCD 83% Are Ventricular Tachyarrhythmias Bradycardia 17% VT 62% Primary VF 8% Torsades de Pointes 13%

6 Adapted from Heikki et al. N Engl J Med, Vol. 345, No. 20, % Coronary Artery Disease 15% Cardiomyopathy 5% Other* Underlying Causes of Fatal Arrhythmias Coronary Artery Disease is Most Common *ion-channel abnormalities, valvular or congenital heart disease, other causes

7 Mechanisms of VT/VF in Acute Ischemia Dispersion of refractoriness –Potassium current Alteration of conduction velocity and propagation –Sodium current Enhanced abnormal automaticity –Calcium current

8 Dispersion of Refractoriness Alteration of potassium handling alters local action potential duration/refractoriness –Regional increase in interstitial concentration related to cell lysis –Accumulation of ADP in ischemic tissue directly alters cellular potassium current

9 Altered Conduction Velocity Lack of mitochondrial function/ATP results in loss of sodium/calcium current –Slowed and differential conduction Spontaneous multifocal ventricular ectopy –Abnormal automaticity related to altered calcium current

10 VT/VF in Acute Ischemia Multifactorial Mechanisms Altered handling of sodium, potassium and calcium current Dispersion of refractoriness/ areas of functional block Differential conduction propagation/velocity Multifocal automatic discharges Promotes local reentry and prompt degeneration into PMVT/VF Thus if a patient presents with monomorphic VT it rarely is related to acute ischemia

11 VT in Chronic Ischemic Heart Disease Scar from Prior MI –Establishes a zone of slow conduction Tissue within the infarct that is viable but not healthy Conduction is slow…essential substrate to establish reentry Random ventricular ectopy that otherwise would be benign becomes malignant in setting of scar and slow conduction –Reentry

12 ACC/AHA/HRS Guidelines: Indications for ICDs Class III Indication: Ventricular tachyarrhythmias due to a transient or reversible disorder (e.g., acute MI, electrolyte imbalance, drugs, or trauma) when correction of the disorder is considered feasible and likely to substantially reduce the risk of recurrent arrhythmias. Level of evidence: B.

13 How Reversible Are Reversible Causes (e.g., Ischemia) of SCD? In every ICD clinical trial: –Patients with sustained VT or VF due to an identifiable transient or correctable cause have been excluded Presumption that these patients are at low risk for recurrent malignant ventricular arrhythmias, thus little benefit for ICD –No clinical trials to support this approach

14 AVID Trial: Amiodarone Versus ICD for Secondary Prevention VT/VF, EF < 40% Registry of all patients screened Excluded patients with transient or correctable cause of VT/VF Wyse et al, JACC 2001: Assessed mortality of – patients screened but excluded from AVID due to correctable cause versus –patients enrolled in AVID for secondary prevention of VT/VF and who received an ICD

15 Transient/Reversible Causes Determined by the AVID principal investigator at each site Classified as –New Q-wave MI –New non Q-wave MI –Other ischemic event –Proarrhythmic drug reaction –Electrolyte imbalance (hypo-K/-Mg) –Other

16 Transient or Correctable Causes of VT/VF (n = 278) Wyse, et al. J Am Coll Cardiol 2001;38: Ischemic events New MI Non-Q-wave Q-wave Transient ischemia, no MI Other or unknown* Electrolyte imbalance Antiarrhythmic drug reaction n % 65.8% 57.9% 29.9% 28.0% 7.9% 17.9% 9.7% 6.5% *Cocaine, or illicit drug use, sepsis, hypoxia, electrocution, drowning and other

17 Patients with Primary VT/VF versus VT/VF due to Transient/Correctable Cause n Age (yrs) LVEF Men CAD Cardiomyoapthy Prior history VF VT Atrial fibrillation MI CHF Diabetes CABG/PTCA AAD Primary 2, ± ± % 74.9% 3.1% 4.3% 15.0% 22.3% 57.5% 38.4% 17.8% 26.2% 13.1% Transient Correctable Cause ± ± % 82.0% 2.9% 9.7% 18.7% 44.2% 21.6% 15.8% 18.7% 13.7% p Value < < Wyse, et al. J Am Coll Cardiol 2001;38: Transient Cause: Younger, Better EF with Less HF, Less MI …but with More CAD and Less Revascularization

18 Survival Curves of Primary VT/VF vs Transient/Correctable Cause for VT/VF After adjustment for differences in patient variables – 90 – 80 – 70 – 60 – 50 – Days Cumulative Survival Primary VT/VF Transient VT/VF No. at Risk Primary VT/VF Transient VT/VF p = Wyse, et al. J Am Coll Cardiol 2001;38:

19 Survival Curves for Non Q wave MI, Q wave MI, and Ischemia Without MI Patients with a transient/correctable cause for VT/VF – 0.9 – 0.8 – 0.7 – 0.6 – 0.5 – Days Cumulative Survival Non Q wave MI, n=83 Ischemia w/o MI, n= Q wave MI, n=78 Wyse, et al. J Am Coll Cardiol 2001;38: p = NS

20 VT/VF in Setting of Acute Ischemia and Preserved EF (No Scar) Often Exercise related Considered low risk for recurrent VT/VF after successful management of ischemia How many pts have only 1 Ischemic event? Compliance with medical therapy Reversibility of contributing features: DM, HTN, Hyperlipidemia Few trials

21 VT/VF in Setting of Acute Ischemia and Depressed EF/Prior Scar due to Prior MI Is VT/VF due to transient ischemia or due to scar-mediated VT or multifactorial? Will revascularization prevent further episodes of SCD? What is the impact of revascularization on scar? Will revascularization manage a reentrant VT circuit?

22 Retrospective review of 58 pts with SCD and CABG with ICD placement EP testing before and after CABG Mean EF 31%; F/U of 4.6 years 22/58 (38%) with appropriate ICD therapies EP testing was not predictive –Including post CABG EP testing Impact of CABG on SCD Natale et al 1994 J Cardiovasc Electrophysiol

23 Impact of CABG on SCD Daoud et al, 1995 Am Heart J 23 pts survived SCD + noninducible at EP testing + ischemia on stress testing CABG + ICD Mean EF 28%; F/U 3.1 years 10/23 (43%) with ICD shocks –No clinical differences between pt with vs without ICD shocks Conclusion: CABG not protective; no variables predicted ICD therapy

24 Conclusion: Transient (Acute) Ischemic Causes of VT/VF Limited research…presumed not to be at increased risk for recurrent arrhythmias It is sometimes difficult to ascertain with confidence that the VT/VF is reversible Approach must be individualized for the patient and clinical scenario Accomplish 3 goals: –Correctly identify all contributing features; and, –Fully correct the reversible cause(s); and, –High degree of confidence that reversible cause(s) will not recur

Download ppt "Myocardial Ischemia: An Underrated Cause of Sudden Cardiac Death? William T. Abraham, MD, FACP, FACC, FAHA Professor of Medicine, Physiology, and Cell."

Similar presentations

Ads by Google